Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(7 sites)
United States
The University of Alabama at Birmingham, South Birmingham, Alabama UCLA Health, Santa Monica, California Massachusetts General Hospital, Boston, Massachusetts Brigham and Women's Hospital (BWH), Boston, Massachusetts Boston Medical Center (BMC), Boston, Massachusetts